Board of Scientific Counselors, Office of Public Health Preparedness and Response, (BSC, OPHPR), 17666 [2017-07325]
Download as PDF
<![CDATA[
17666
Federal Register / Vol. 82, No. 69 / Wednesday, April 12, 2017 / Notices
research, miner health program, and
hazard recognition project for stone,
sand and gravel mines. The meeting will
also include updates from the National
Personal Protective Technology
Laboratory and the Respiratory Health
Division.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Jeffrey H. Welsh, Designated Federal
Officer, MSHRAC, NIOSH, CDC, 626
Cochrans Mill Road, Pittsburgh, PA
15236, telephone 412–386–4040, fax
412–386–6614.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both CDC and
the Agency for Toxic Substances and
Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention (CDC).
[FR Doc. 2017–07324 Filed 4–11–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on DSK30JT082PROD with NOTICES
Board of Scientific Counselors, Office
of Public Health Preparedness and
Response, (BSC, OPHPR)
In accordance with section 10 (a) (2)
of the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Times and Dates:
10:00 a.m.–5:00 p.m., EDT, May 10,
2017
8:30 a.m.–3:30 p.m., EDT, May 11, 2017
Place: Centers for Disease Control and
Prevention (CDC), Global
Communications Center, Building 19,
Auditorium B3, 1600 Clifton Road NE.,
Atlanta, Georgia 30333
Status: Open to the public limited
only by the space available. The meeting
room will accommodate up to 75
people. Public participants should preregister for the meeting as described
below.
Members of the public that wish to
attend this meeting in person should
pre-register by submitting the following
information by email, facsimile, or
phone (see Contact Person for More
Information) no later than 12:00 noon
(EDT) on Tuesday, May 3, 2017:
VerDate Sep<11>2014
19:24 Apr 11, 2017
Jkt 241001
•
•
•
•
•
Full Name
Organizational Affiliation
Complete Mailing Address
Citizenship
Phone Number or Email Address
Web conferencing information:
Web ID: https://
adobeconnect.cdc.gov/r7mcyvjvzdh/.
Dial in number: 800–369–1179
Participant passcode: 6329989.
Purpose: This Board is charged with
providing advice and guidance to the
Secretary, Department of Health and
Human Services (HHS), the Assistant
Secretary for Health (ASH), the Director,
Centers for Disease Control and
Prevention (CDC), and the Director,
Office of Public Health Preparedness
and Response (OPHPR), concerning
strategies and goals for the programs
and research within OPHPR, monitoring
the overall strategic direction and focus
of the OPHPR Divisions and Offices,
and administration and oversight of
peer review for OPHPR scientific
programs. For additional information
about the Board, please visit: https://
www.cdc.gov/phpr/science/
counselors.htm.
Matters for Discussion: Day one of the
meeting will cover briefings and BSC
deliberation on the following topics:
interval updates from OPHPR Divisions
and Offices; establishing a BSC working
group to address biological agent
containment; federal and state
perspectives on the opioid overdose
epidemic as a public health emergency;
and BSC liaison representative updates
to the Board highlighting organizational
activities relevant to the OPHPR
mission.
Day two of the meeting will cover
briefings and BSC deliberation on the
following topics: OPHPR policy agenda
update; natural disaster preparedness
and response; global health security;
and perspectives on CDC as a response
organization.
Contact Person for More Information:
Dometa Ouisley, Office of Science and
Public Health Practice, Centers for
Disease Control and Prevention, 1600
Clifton Road NE., Mailstop D–44,
Atlanta, Georgia 30333, Telephone:
(404) 639–7450; Facsimile: (404)471–
8772; Email: OPHPR.BSC.Questions@
cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
Prevention, and Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Service Office, Centers for Disease Control
and Prevention.
[FR Doc. 2017–07325 Filed 4–11–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors, Office
of Infectious Diseases (BSC, OID)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Times and Dates: 8:30 a.m.–5:00 p.m.,
EDT, May 3, 2017; 8:30 a.m.–12:00 p.m.,
EDT, May 4, 2017.
Place: CDC, Global Communications
Center, 1600 Clifton Road NE., Building
19, Auditorium B3, Atlanta, Georgia
30329.
Status: The meeting is open to the
public, limited only by the space
available. The meeting room will
accommodate up to 100 people.
Purpose: The BSC, OID, provides
advice and guidance to the Secretary,
Department of Health and Human
Services; the Director, CDC; the
Director, OID; and the Directors of the
National Center for Immunization and
Respiratory Diseases, the National
Center for Emerging and Zoonotic
Infectious Diseases, and the National
Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention, CDC, in the
following areas: Strategies, goals, and
priorities for programs; research within
the national centers; and overall
strategic direction and focus of OID and
the national centers.
Matters for Discussion: The meeting
will include updates from CDC’s
infectious disease national centers;
reports from the BSC’s Food Safety
Modernization Act Surveillance
Working Group and Infectious Disease
Laboratory Working Group; and focused
discussions on priority emerging
infectious diseases including
antimicrobial resistance, influenza, and
selected zoonotic and vector-borne
diseases.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Robin Moseley, M.A.T., Designated
Federal Officer, OID, CDC, 1600 Clifton
E:\FR\FM\12APN1.SGM
12APN1
]]>Agencies
[Federal Register Volume 82, Number 69 (Wednesday, April 12, 2017)]
[Notices]
[Page 17666]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-07325]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, Office of Public Health
Preparedness and Response, (BSC, OPHPR)
In accordance with section 10 (a) (2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting of the aforementioned
committee:
Times and Dates:
10:00 a.m.-5:00 p.m., EDT, May 10, 2017
8:30 a.m.-3:30 p.m., EDT, May 11, 2017
Place: Centers for Disease Control and Prevention (CDC), Global
Communications Center, Building 19, Auditorium B3, 1600 Clifton Road
NE., Atlanta, Georgia 30333
Status: Open to the public limited only by the space available. The
meeting room will accommodate up to 75 people. Public participants
should pre-register for the meeting as described below.
Members of the public that wish to attend this meeting in person
should pre-register by submitting the following information by email,
facsimile, or phone (see Contact Person for More Information) no later
than 12:00 noon (EDT) on Tuesday, May 3, 2017:
Full Name
Organizational Affiliation
Complete Mailing Address
Citizenship
Phone Number or Email Address
Web conferencing information:
Web ID: https://adobeconnect.cdc.gov/r7mcyvjvzdh/.
Dial in number: 800-369-1179 Participant passcode: 6329989.
Purpose: This Board is charged with providing advice and guidance
to the Secretary, Department of Health and Human Services (HHS), the
Assistant Secretary for Health (ASH), the Director, Centers for Disease
Control and Prevention (CDC), and the Director, Office of Public Health
Preparedness and Response (OPHPR), concerning strategies and goals for
the programs and research within OPHPR, monitoring the overall
strategic direction and focus of the OPHPR Divisions and Offices, and
administration and oversight of peer review for OPHPR scientific
programs. For additional information about the Board, please visit:
https://www.cdc.gov/phpr/science/counselors.htm.
Matters for Discussion: Day one of the meeting will cover briefings
and BSC deliberation on the following topics: interval updates from
OPHPR Divisions and Offices; establishing a BSC working group to
address biological agent containment; federal and state perspectives on
the opioid overdose epidemic as a public health emergency; and BSC
liaison representative updates to the Board highlighting organizational
activities relevant to the OPHPR mission.
Day two of the meeting will cover briefings and BSC deliberation on
the following topics: OPHPR policy agenda update; natural disaster
preparedness and response; global health security; and perspectives on
CDC as a response organization.
Contact Person for More Information: Dometa Ouisley, Office of
Science and Public Health Practice, Centers for Disease Control and
Prevention, 1600 Clifton Road NE., Mailstop D-44, Atlanta, Georgia
30333, Telephone: (404) 639-7450; Facsimile: (404)471-8772; Email:
OPHPR.BSC.Questions@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both the Centers for Disease Control and Prevention, and Agency for
Toxic Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and Service Office, Centers for
Disease Control and Prevention.
[FR Doc. 2017-07325 Filed 4-11-17; 8:45 am]
BILLING CODE 4163-18-P
